U.S. Markets close in 1 hr 48 mins

Weekly CFO Buys Highlight

- By Myra Ramdenbourg

According to GuruFocus Insider Data, the recent CFO buys were: Genesis Energy LP (GEL), Dentsply Sirona Inc. (XRAY), and Leap Therapeutics Inc. (LPTX).

Genesis Energy LP: CFO Robert V Deere bought 45,000 shares

CFO Robert V Deere bought 45,000 shares for $21.71 per share on Nov. 21. The stock price has decreased by 0.6%. Genesis Energy LP has a market cap of $2.65 billion and its shares were traded around $21.58. The company has a P/E ratio of 30.40 and P/S ratio of 1.48. The trailing 12-month dividend yield of Genesis Energy LP stocks is 12.30%, while the forward dividend yield is 9.22%. Over the past 10 years, Genesis Energy LP had an annual average earnings growth of 11.80%.


Genesis Energy LP announced its 2017 third-quarter results with revenues of $486.11 million and gross profit of $126.24 million; the net income was $6.31 million. The 2016 total revenue was $1.71 billion, a 24% decrease from the 2015 total revenue. The 2016 gross profit was $474.25 million, a 27% increase from the 2015 gross profit. The 2016 net income was $113.25 million.

CEO Grant E Sims bought 44,263 shares for $22.93 per share on Nov. 10. The stock price has decreased by 5.89%. Director James E Davison bought 20,969 shares for $21.68 per share on Nov. 21. The stock price has decreased by 0.46%. President, Genesis Alkali, LLC Edward T Flynn bought 4,681 shares for $21.32 per share on Nov. 16. The stock price has increased by 1.22%.

Dentsply Sirona Inc.: EVP, CFO Nicholas W Alexos bought 50,000 shares

EVP, CFO Nicholas W Alexos bought 50,000 shares for $65.85 per share on Nov. 13. The stock price has increased by 1.76%. Dentsply Sirona Inc. has a market cap of $15.39 billion and its shares were traded around $67.01. The company has a P/S ratio of 4.00. The trailing 12-month dividend yield of Dentsply Sirona Inc stocks is 0.51%, while the forward dividend yield is 0.53%. Over the past 10 years, Dentsply Sirona Inc. had an annual average earnings growth of 4.00%. GuruFocus rated Dentsply Sirona Inc. the business predictability rank of 3-star.

Dentsply Sirona announced its 2017 third-quarter results with revenues of $1.01 billion and gross profit of $559 million; the net income was $90.6 million. The 2016 total revenue was $3.75 billion, a 40% increase from the 2015 total revenue. The 2016 gross profit was $2 billion, a 32% increase from the 2015 gross profit. The 2016 net loss was $429.9 million.

Interim Chief Exec Officer Mark Thierer bought 77,000 shares for $66.04 per share on Nov. 13. The stock price has increased by 1.47%. Director Francis J Lunger sold 8,900 shares for $65.9 per share on Nov. 13. The stock price has increased by 1.68%.

Leap Therapeutics Inc.: CFO, GC, Treasurer and Secretary, 10% Owner Douglas E Onsi bought 1,057,769 shares

CFO, GC, Treasurer and Secretary, 10% Owner Douglas E Onsi bought 1,057,769 shares for $6.09 per share on Nov. 14. The stock price has increased by 17.24%. Leap Therapeutics Inc. has a market cap of $65.790 million and its shares were traded around $7.00.

CEO, President, COB, 10% Owner Christopher Mirabelli bought 1,057,769 shares for $6.09 per share on Nov. 14. The stock price has increased by 17.24%. 10% Owner Ventures Ix, L.p. Healthcare bought 1,057,769 shares for $6.09 per share on Nov. 14. The stock price has increased by 17.24%. COO, 10% Owner Augustine Lawlor bought 1,057,769 shares for $6.09 per share on Nov. 14. The stock price has increased by 17.24%.

Disclosure: none

This article first appeared on GuruFocus.